X

    XOMA (XOMA)

    Official site

    BIOTECHNOLOGY

    $40.17
    +0.00 (+0.00%)

    Last updated: Jul 14, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    51%(20/39)
    Avg Surprise
    +61.36%
    Streak
    6 Q

    Upcoming Estimates

    Jun 30, 2026
    EPS Consensus$0.50
    Range$0.50 - $0.50
    1 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$0.23-54.5%
    60d ago$0.17-65.0%
    30d ago$0.17-65.0%
    7d ago$0.17-65.0%
    Current$0.50
    Revenue Consensus
    $16M
    Range$16M - $16M
    1 analysts
    Sep 30, 2026
    EPS Consensus$0.52
    Range$0.52 - $0.52
    1 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$0.38-26.4%
    60d ago$0.26-50.0%
    30d ago$0.26-50.0%
    7d ago$0.26-50.0%
    Current$0.52
    Revenue Consensus
    $16M
    Range$16M - $16M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.64---
    Sep 26EST
    		-$0.52---
    Jun 26EST
    		-$0.50---
    Mar 26
    		$0.17$-0.06+414.55%Beat+188.3%
    Dec 25
    		$0.08$-0.09+188.89%Beat+233.3%
    Sep 25
    		$0.70$-0.04+1850.00%Beat+144.0%
    Jun 25
    		$0.44$-0.15+393.33%Beat-47.6%
    Mar 25
    		$0.06N/A+122.22%Beat+107.0%
    Dec 24
    		$-0.06N/A+80.22%Beat+87.8%
    Sep 24
    		$-1.59$-0.41-287.80%Miss-165.0%
    Jun 24
    		$0.84$-0.27+411.11%Beat+242.4%
    Mar 24
    		$-0.86$-0.81-6.17%Miss+12.2%
    Dec 23
    		$-0.49$-0.36-36.11%Miss+22.2%
    Sep 23
    		$-0.60$-0.48-25.00%Miss-25.0%
    Jun 23
    		$-0.59$-0.52-13.46%Miss-11.3%
    Mar 23
    		$-0.98$-0.49-100.00%Miss-206.2%
    Dec 22
    		$-0.63$-0.47-34.04%Miss-137.7%
    Sep 22
    		$-0.48$-0.23-108.70%Miss+5.9%
    Jun 22
    		$-0.53$-0.16-231.25%Miss-82.8%
    Mar 22
    		$-0.32$-0.53+39.62%Beat+54.3%
    Dec 21
    		$1.67$2.27-26.43%Miss+26.5%
    Sep 21
    		$-0.51$-0.20-155.00%Miss-410.0%
    Jun 21
    		$-0.29$-0.31+6.45%Beat+12.1%
    Mar 21
    		$-0.70$-0.15-366.67%Miss-42.9%
    Dec 20
    		$1.32$2.00-34.00%Miss+369.4%
    Sep 20
    		$-0.10N/A+61.54%Beat-150.0%
    Jun 20
    		$-0.33$-0.38+13.16%Beat+29.8%
    Mar 20
    		$-0.49$-0.16-206.25%Miss-333.3%
    Dec 19
    		$-0.49$-0.27-81.48%Miss-40.0%
    Sep 19
    		$0.20N/A+141.67%Beat+145.5%
    Jun 19
    		$-0.47$-0.55+14.55%Beat-104.3%
    Mar 19
    		$0.21$-0.12+275.00%Beat+145.7%
    Dec 18
    		$-0.35$-0.49+28.57%Beat-118.7%
    Sep 18
    		$-0.44$-0.40-10.00%Miss-22.2%
    Jun 18
    		$-0.23$-0.36+36.11%Beat-209.5%
    Mar 18
    		$-0.46$-0.53+13.21%Beat+70.3%
    Dec 17
    		$-0.16N/A+54.29%Beat+92.5%
    Sep 17
    		$-0.36$-0.72+50.00%Beat+82.7%
    Jun 17
    		$0.21N/A-64.41%Miss-
    Mar 17
    		$-1.55$-1.29-20.16%Miss-
    Dec 16
    		$-2.12$-2.36+10.17%Beat-
    Sep 16
    		$-2.08$-1.99-4.52%Miss-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$43.02
    SMA 20$42.51
    SMA 50$42.04
    SMA 200$33.72
    EMA 10$42.50
    EMA 20$42.49
    EMA 50$41.15
    EMA 200$34.82

    MACD

    Line: 0.21Signal: 0.50Hist: -0.29

    ADX

    ADX: 33.1+DI: 22.0-DI: 40.0

    Aroon & PSAR

    Aroon Up88.0
    Aroon Down96.0
    PSAR$45.11

    Bollinger Bands

    Upper Band$45.11
    Lower Band$39.91
    %B Position1225%(Upper)
    Band Width0.05

    RSI (14-Day)

    Neutral
    34.3

    Momentum Oscillators

    Stoch %K30.8
    Stoch %D59.1
    Williams %R-92.7
    ROC (10d)-4.7%
    Momentum-1.98
    CCI (20d)-172.7
    MFI (14d)23.5

    Volatility Measures

    ATR (14d)$0.84(2.1%)
    StdDev (20d)1.30
    Hist Vol36.0%(Moderate)

    Volume Flow

    VWAP$40.17
    OBV-6.1M
    AD Line-4.0M
    CMF (20d)-0.463

    Volume Metrics

    Avg Vol (20d)510.0K
    Vol RatioN/A
    VWMA (20d)$41.14

    Pivot Points

    R3$47.04
    R2$45.50
    R1$42.84
    Pivot Point$41.30
    S1$38.64
    S2$37.10
    S3$34.44

    Advanced Oscillators

    TSI9.83
    Ultimate Osc44.8
    KST25.55

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$12.32M$13.76M$9.35M$13.13M$15.91M$8.71M$7.20M$11.09M$1.49M$1.83M$830,000$1.66M
    Cost of Revenue$0$884,000$0$0$0$864,000$0$0$0$25,000$0$0
    Gross Profit$12.32M$13.76M$9.35M$13.13M$15.91M$8.71M$7.20M$11.09M$1.49M$1.83M$830,000$1.66M
    Operating Expenses$12.80M$11.57M$10.68M$8.53M$9.98M$15.97M$22.84M$21.16M$8.49M$21.77M$6.62M$7.62M
    R&D$49,000$281,000$69,000$69,000$1.29M$864,000$817,000$1.16M$33,000$25,000$25,000$39,000
    SG&A$11.86M$10.41M$9.73M$7.80M$8.15M$6.99M$8.02M$11.00M$8.46M$7.26M$6.37M$5.78M
    Operating Income$-480,000$2.18M$-1,330,000$4.60M$5.93M$-7,253,000$-15,640,000$-10,079,000$-7,004,000$-19,934,000$-5,787,000$-5,957,000
    Interest Income$3.54M$0$18.00M$0$0$0$0$19.32M$0$0$0$0
    Interest Expense$3.36M$3.03M$3.30M$3.24M$3.47M$3.39M$3.49M$3.40M$3.55M$569,000$0$0
    Income Before Tax$4.47M$6.16M$14.10M$9.19M$2.37M$-9,626,000$-17,243,000$15.98M$-8,595,000$-19,752,000$-5,509,000$-5,400,000
    Income Tax Expense$1,000$0$49,000$0$0$0$0$0$0$0$0$0
    Net Income$4.46M$6.10M$14.05M$9.19M$2.37M$-3,968,000$-17,243,000$15.98M$-8,595,000$-20,109,000$-5,509,000$-5,400,000
    EBITDA$5.51M$7.10M$664,000$13.41M$6.81M$-5,670,000$-13,259,000$276,000$-4,736,000$-19,675,000$-5,285,000$-5,175,000
    EBIT$4.28M$5.96M$-603,000$12.43M$5.83M$-6,232,000$-13,750,000$71,000$-5,044,000$-19,934,000$-5,509,000$-5,400,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about XOMA

    News

    XOMA Royalty Corp (XOMA) Stock News Today

    The article provides current stock information for XOMA Royalty Corp (XOMA), including its stock price, market capitalization, and P/E ratio. It indicates that more news and analysis for XOMA is forthcoming, encouraging users to stay tuned for updates on earnings, analyst ratings, and key developments. The page also offers various tools and data related to XOMA's financial performance and market standing.

    TradingKey•8/7/26•
    Neutral

    FMR LLC (XOMA) cuts XOMA Royalty stake to 0.0% in latest 13G/A

    FMR LLC and Abigail P. Johnson have filed an amended passive investment disclosure (Schedule 13G/A) for XOMA Royalty Corporation, indicating that they no longer beneficially own any shares. As of July 31, 2026, they report holding 0.00 shares, representing 0.0% of the total outstanding common stock, with no voting or dispositive power. This filing confirms that FMR LLC no longer holds 5% or more of XOMA Royalty stock.

    Stock Titan•8/7/26•
    Neutral

    FMR LLC boosts disclosure in XOMA Royalty Corporation (XOMA) with 9.1% stake

    FMR LLC has disclosed a 9.1% stake in XOMA Royalty Corporation (XOMA) through an amended Schedule 13G/A filing. As of June 30, 2026, FMR LLC beneficially owns 1,605,532.14 shares, with Fidelity Contrafund holding 5.4% of these shares. Abigail P. Johnson is also listed as a reporting person with sole dispositive power over the same number of shares.

    Stock Titan•8/6/26•
    Neutral

    US98419J206 Stock Price and Chart — MUN:US98419J206

    This article provides detailed financial information and key statistics for XOMA Royalty Corporation (US98419J206) traded on the Munich Stock Exchange. It covers market capitalization, dividend yield, EPS, revenue, employee data, and upcoming earnings. The company profile highlights its business model as a biotech royalty aggregator focusing on early to mid-stage clinical assets.

    TradingView•8/3/26•
    Neutral

    Vanguard Capital Management (XOMA) discloses 571,823-share passive stake in XOMA

    Vanguard Capital Management LLC has filed an amended Schedule 13G, disclosing a passive stake of 571,823 shares in XOMA Royalty Corp, representing 3.23% of the outstanding common stock as of June 30, 2026. Vanguard has sole voting power over 66,658 shares and sole dispositive power over all 571,823 shares, with no other entity holding more than a 5% interest through these holdings. This filing indicates an investment purpose rather than an intent to control or influence the company.

    Stock Titan•7/31/26•
    Neutral

    Frequently Asked Questions About XOMA

    Does XOMA pay dividends?
    XOMA (XOMA) does not currently pay a regular dividend.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In